View Article

  • Analytical Method Development and Validation of Carvedilol Using UV and RP-HPLC Techniques

  • Dr. Vedprakash Patil pharmacy college, Chhatrapati Sambhajinagar, Maharashtra 431105.

Abstract

A common non-selective beta-adrenergic blocker used to treat heart failure, hypertension, and left ventricular dysfunction is carvingilol. For its quantitative estimate in pharmaceutical dosage forms and bulk pharmaceuticals to guarantee purity, safety, and efficacy, accurate and trustworthy analytical techniques are crucial. The development and validation of analytical techniques for Carvedilol utilising reverse-phase high-performance liquid chromatography (RP-HPLC) and ultraviolet (UV) spectrophotometry are the main topics of this study. UV spectroscopy techniques are straightforward, quick, and economical; they typically entail calculating the maximum absorbance (?max) and calibration curves within an appropriate linearity range. However, when contaminants or degradation products are present, these techniques might not be as specific. RP-HPLC techniques, on the other hand, are appropriate for regular quality control and stability investigations because to their great sensitivity, accuracy, and specificity. A common non-selective beta-adrenergic blocker used to treat heart failure, hypertension, and left ventricular dysfunction is carvingilol. For its quantitative estimate in pharmaceutical dosage forms and bulk pharmaceuticals to guarantee purity, safety, and efficacy, accurate and trustworthy analytical techniques are crucial. The development and validation of analytical techniques for Carvedilol utilising reverse-phase high-performance liquid chromatography (RP-HPLC) and ultraviolet (UV) spectrophotometry are the main topics of this study. UV spectroscopy techniques are straightforward, quick, and economical; they typically entail calculating the maximum absorbance (?max) and calibration curves within an appropriate linearity range. However, when contaminants or degradation products are present, these techniques might not be as specific. RP-HPLC techniques, on the other hand, are appropriate for regular quality control and stability investigations because to their great sensitivity, accuracy, and specificity.

Keywords

Carvedilol, UV Spectrophotometry, RP-HPLC, Method Development, Method Validation, International Council for Harmonisation Guidelines, Linearity, Accuracy, Precision, Stability-Indicating Method, Pharmaceutical Analysis

Introduction

A common cardiovascular medication, Carvedilol is a member of the family of non-selective beta-adrenergic blockers that also has alpha α-blocking properties. It is widely used to treat congestive heart failure, hypertension, and left ventricular dysfunction after myocardial infarction. Because of its distinct pharmacological profile, carvingilol improves total cardiac output and lowers peripheral resistance by causing vasodilation in addition to lowering heart rate and myocardial contractility. Carvedilol is a key medication in contemporary cardiovascular treatment because of these therapeutic advantages1-2.

The chemical formula for Carvedilol is (±)-1-(carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy) ethyl] amino]-2-propanol. Its limited water solubility and lipophilic nature may affect how it is formulated and determined analytically.

The medication may be analysed using UV spectrophotometric methods because of its significant absorption in the ultraviolet spectrum. Furthermore, reverse-phase high-performance liquid chromatography (RP-HPLC) may be used to separate and quantify it due to its chemical structure and polarity. The development of precise, accurate, and trustworthy analytical techniques for drug estimate is imperative due to the increasing demand for high-quality pharmaceutical goods3-4. In order to guarantee the identification, purity, potency, and stability of pharmaceutical substances, analytical technique development is essential. In the case of Carvedilol, analytical techniques are crucial for stability testing, dissolution studies, pharmacokinetic research, and regular quality control of bulk medications and dosage forms.

The most widely used analytical techniques for the analysis of Carvedilol are RP-HPLC and UV spectrophotometry. Due to its ease of use, speed, and affordability, UV spectrophotometry is often employed5-6.

It entails measuring the drug's absorbance at a certain wavelength (λmax) and then creating calibration curves for quantitative quantification. UV spectroscopy has significant drawbacks despite its benefits, including less selectivity and possible interference from excipients or degradation products.

RP-HPLC, on the other hand, is an extremely advanced and dependable analytical method that provides excellent sensitivity, specificity, and repeatability. Components are separated according to how they interact with a polar mobile phase and a non-polar stationary phase. To ensure effective separation and precise quantification, a number of parameters are optimised during the development of the RP-HPLC technique for Carvedilol, including column type (often C18), mobile phase composition (such as acetonitrile and buffer mixes), flow rate, pH, and detection wavelength. When analysing complicated pharmaceutical formulations and stability-indicating investigations, where the presence of contaminants and degradation products has to be precisely detected and quantified, RP-HPLC is very helpful7-8.

Analytical procedures must be validated in order to guarantee that they are appropriate for the intended usage. The International Council for Harmonization's requirements, namely ICH Q2 (R1), are followed for validating methods. These recommendations provide a number of validation factors, such as robustness, system appropriateness, linearity, accuracy, precision, specificity, limit of detection (LOD), and limit of quantification (LOQ)9. Validation guarantees that, under predetermined circumstances, the established process yields dependable and repeatable results10.

The development of stability-indicating procedures is another crucial component of analytical method development. Carvedilol behaviour in a variety of stress conditions, including acidic, basic, oxidative, thermal, and photolytic environments, is assessed by stability tests. These investigations aid in the identification of possible degradation products and guarantee that the analytical technique can successfully separate and measure the medication in the presence of such degrades. Because they offer comprehensive details regarding the drug's stability profile, stability-indicating RP-HPLC techniques are very useful in pharmaceutical analysis11-13.

The development of economical and ecologically friendly analytical techniques has received more attention in recent years. Green analytical chemistry techniques seek to preserve analytical performance while minimising the usage of dangerous solvents and waste production. For the analysis of Carvedilol, attempts have been made to create streamlined UV techniques and improved RP-HPLC techniques with lower solvent consumption and shorter run durations. More complex methods like liquid chromatography–mass spectrometry (LC-MS/MS) and ultra-performance liquid chromatography (UPLC) have been developed as a result of improvements in analytical equipment. Due to their accessibility, cost, and appropriateness for regular analysis in pharmaceutical laboratories, UV spectrophotometry and RP-HPLC continue to be the most used techniques, despite the fact that these techniques provide improved sensitivity and selectivity14-15.

Drug Profile of Carvedilol:

 

Table.1: Drug Profile of Carvedilol16-18

Parameter

Details

Drug Name

Carvedilol

Category

Non-selective β-adrenergic blocker with α?-blocking activity

IUPAC Name

(±)-1-(Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol

Molecular Formula

C??H??N?O?

Molecular Weight

406.47 g/mol

Structure

Contains carbazole nucleus with ether and amine functional groups

Appearance

White to off-white crystalline powder

Solubility

Poorly soluble in water; soluble in methanol, ethanol

pKa

~7.8

Log P (Partition Coefficient)

~4.2 (lipophilic)

Melting Point

114–116°C

λmax (UV Absorption)

~240–285 nm (varies with solvent)

Pharmacological Class

Antihypertensive agent

Mechanism of Action

Blocks β?, β?, and α? receptors → reduces heart rate & causes vasodilation

Indications

Hypertension, congestive heart failure, myocardial infarction

Bioavailability

~25–35% (due to first-pass metabolism)

Half-life

6–10 hours

Metabolism

Hepatic (extensive first-pass metabolism)

Excretion

Mainly via bile and feces

Dosage Forms

Tablets, capsules

Protein Binding

~95–98%

Storage Conditions

Store in a cool, dry place away from light

 

Analytical Techniques Overview:

Analytical methods are essential for determining pharmaceutical substances both qualitatively and quantitatively. Two of the most used methods for carvingilol are reverse-phase high-performance liquid chromatography (RP-HPLC) and UV spectrophotometry. Because of their precision, dependability, and suitability for regular quality control and research, these techniques are widely employed19.

1. Principle of UV Spectrophotometry- The basis of UV spectrophotometry is the absorption of UV light by chromophore-containing molecules. Carvedilol shows notable UV absorption because of its aromatic carbazole structure. According to Beer-Lambert's law, the amount of light absorbed is directly correlated with the drug's concentration20.

Instrumentation

A typical UV spectrophotometer consists of:

  • Light source (Deuterium lamp for UV region)
  • Monochromator
  • Sample holder (cuvette)
  • Detector
  • Data processing system21-22

Methodology for Carvedilol

  • Selection of suitable solvent (e.g., methanol, ethanol)
  • Determination of maximum wavelength (λmax), generally around 240–285 nm
  • Preparation of standard solutions
  • Construction of calibration curve (absorbance vs. concentration)22

2. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC)

Principle

RP-HPLC is based on the separation of analytes between a non-polar stationary phase and a polar mobile phase. Carvedilol, being moderately lipophilic, interacts strongly with the stationary phase, allowing effective separation from impurities and degradation products23.

Instrumentation

RP-HPLC system includes:

  • Solvent reservoir
  • Pump (for mobile phase delivery)
  • Injector
  • Column (commonly C18)
  • Detector (UV/PDA detector)
  • Data acquisition system24-25

Method Development for Carvedilol

  • Column selection: C18 column (most commonly used)
  • Mobile phase: Mixture of acetonitrile and buffer (e.g., phosphate buffer)
  • Flow rate: Typically 0.8–1.5 mL/min
  • Detection wavelength: Around 240–285 nm
  • Injection volume: Usually 10–20 µL
  • Retention time: Depends on method optimization25

Table.2: Comparative study of UV Spectrophotometry and RP-HPLC26-27

Parameter

UV Spectrophotometry

RP-HPLC

Principle

Absorbance of UV light

Chromatographic separation

Sensitivity

Moderate

High

Specificity

Low

High

Cost

Low

High

Time

Fast

Moderate

Application

Routine analysis

Advanced & stability studies

Method Development for Carvedilol:

To guarantee accurate, precise, and trustworthy drug estimate in bulk and dosage forms, the development of analytical methods for carvingilol is a crucial step in pharmaceutical analysis. In order for an analytical method to produce repeatable findings with the least amount of interference from excipients, contaminants, or degradation products, a variety of experimental settings must be chosen and optimised28-29. The most popular analytical methods for analysing Carvedilol are reverse-phase high-performance liquid chromatography (RP-HPLC) and ultraviolet (UV) spectrophotometry. The initial step in developing a UV spectrophotometric approach is choosing an appropriate solvent where carvingilol shows acceptable stability and solubility. Methanol and ethanol are often used solvents because of their compatibility and low UV interference. To find the maximum absorbance (λmax), a standard stock solution of Carvedilol is made and scanned across the 200–400 nm wavelength range. Depending on the solvent employed, Carvedilol usually exhibits λmax between 240 and 285 nm30.

After determining the λmax, a number of standard solutions at various concentrations are made in order to plot absorbance versus concentration and create a calibration curve. To ensure compliance with Beer-Lambert's law, the method's linearity is assessed within a particular concentration range31. A precisely weighed amount of the pharmaceutical formulation must be dissolved in order to prepare the sample, which is then filtered and diluted appropriately. To attain the highest level of accuracy and precision, a number of factors, including solvent type, wavelength, and concentration range, are optimised.  RP-HPLC technique development, on the other hand, offers greater sensitivity and specificity. The first step in the procedure is choosing a suitable stationary phase, usually a C18 column that works well with somewhat lipophilic substances like Carvedilol32.

To make sure the chromatographic system is operating correctly, system suitability testing is carried out before analysis. To ensure the method's specificity, extra effort is necessary to remove any interference from excipients, contaminants, or degradation products. Method development is greatly influenced by variables that need to be carefully controlled, including pH, solvent composition, column properties, temperature, and drug stability.
A methodical approach is used throughout the whole method development process, which involves choosing the analytical methodology, conducting first experiments, optimising the experimental setup, and finalising the method. The created technique must adhere to the International Council for Harmonization's requirements and be able to yield precise, accurate, and repeatable results33-34.

Method Validation:

To make sure the analytical technique created for Carvedilol is dependable, precise, and repeatable, method validation is a crucial step. The International Council for Harmonization's criteria are followed (ICH Q2 (R1)). Important metrics including linearity, accuracy, precision, specificity, robustness, limit of detection (LOD), limit of quantification (LOQ), and system appropriateness are all evaluated throughout the validation process. Recovery studies are used to establish accuracy, whereas calibration curves over a certain concentration range are used to evaluate linearity. Repeatability and intermediate precision, represented as %RSD, are used to assess precision35.

The method's specificity guarantees that it can test Carvedilol precisely even when excipients and contaminants are present. The method's sensitivity is shown by LOD and LOQ. While system suitability testing verifies that the analytical system is operating correctly, robustness investigates the impact of minor changes in experimental circumstances. In general, validation guarantees that the approach is appropriate for standard pharmaceutical analysis36.

Stability-Indicating Methods:

Analytical techniques that precisely and precisely assess the active pharmaceutical ingredient (API) in the presence of its degradation products, contaminants, and excipients are known as stability-indicating methods. To guarantee Carvedilol quality, safety, and effectiveness over the course of its shelf life, stability-indicating techniques must be developed.
Carvedilol is usually subjected to forced degradation experiments under various stress settings in order to develop stability-indicating methodologies. These include thermal deterioration (exposure to high temperatures), photolytic degradation (exposure to UV or sunlight), acidic and alkaline hydrolysis, and oxidative degradation (using chemicals like hydrogen peroxide). These investigations aid in determining possible degradation products and evaluating the drug's stability profile26-37.

Because of its great sensitivity, specificity, and capacity to distinguish Carvedilol from its degradation products, reverse-phase high-performance liquid chromatography (RP-HPLC) is the most widely utilised technology for creating stability-indicating procedures. Chromatographic settings are optimised throughout technique development to produce well-resolved peaks at the drug's retention period without interference.
To guarantee their dependability, stability-indicating techniques are certified in accordance with the International Council for Harmonization's requirements. These techniques are essential for formulation development, stability testing, and regulatory submissions, which guarantees the constant quality of Carvedilol pharmaceutical goods38-39.

Comparative Evaluation:

 

Table.3: Comparative Evaluation of UV and RP-HPLC Methods40

Parameter

UV Spectrophotometry

RP-HPLC

Principle

Absorbance of UV radiation

Chromatographic separation

Sensitivity

Moderate

High

Specificity

Low

High

Accuracy

Moderate

High

Precision

Moderate

High

Cost

Low

High

Time Required

Fast

Moderate

Sample Preparation

Simple

More complex

Application

Routine analysis

Advanced & stability studies

Detection of Impurities

Not effective

Highly effective

 

Regulatory Considerations:

  • The International Council for Harmonization's recommendations (ICH Q2(R1)) must be followed in the development and validation of analytical techniques for carvingilol.
  • For pharmaceutical goods to be consistent, high-quality, and safe, the process must adhere to Good Manufacturing Practices (GMP).41
  • Accuracy, precision, specificity, linearity, LOD, and LOQ are examples of validation metrics that must satisfy predetermined acceptance requirements.
  • To determine the shelf life and storage conditions of Carvedilol formulations, stability studies should be carried out in accordance with ICH recommendations (ICH Q1A).
  • For regulatory bodies to approve analytical results, proper paperwork and regulatory filing are necessary42-44.

FUTURE PERSPECTIVES:

  • Creation of environmentally friendly analytical techniques to lessen the usage of dangerous solvents.
  • Increasing the use of cutting-edge methods like UPLC and LC-MS/MS for quicker and more sensitive carvingilol analysis45.
  • Automation and artificial intelligence (AI) are integrated into method development to increase accuracy and decrease human error.
  • For a deeper comprehension of degradation mechanisms, concentrate on stability-indicating and impurity profiling techniques.
  • Using Quality by Design (QbD) techniques to build analytical methods in a methodical and reliable manner46-47.

CONCLUSION

To guarantee Carvedilol purity, safety, and effectiveness in pharmaceutical formulations, analytical techniques must be developed and validated. The significance of reverse-phase high-performance liquid chromatography (RP-HPLC) and UV spectrophotometry as trustworthy methods for the quantitative measurement of Carvedilol is emphasised in this study. Because UV spectrophotometric techniques are quick, easy, and economical, they may be used for regular examination of bulk medications and simple dose forms. Nevertheless, their poor specificity limits their use when contaminants and degradation products are present. RP-HPLC techniques, on the other hand, provide better sensitivity, precision, and specificity, which makes them ideal for complicated formulations, stability investigations, and impurity profiling. For effective separation and repeatable outcomes, chromatographic settings must be optimised. Method validation, carried out in compliance with the International Council for Harmonization's criteria, guarantees that the created procedures satisfy the necessary requirements for repeatability and dependability. Stability-indicating techniques guarantee the drug's integrity under varied stress circumstances and further improve our understanding of degradation behaviour. According to a comparative comparison, RP-HPLC is still the recommended method for thorough pharmaceutical analysis, even if UV techniques are useful for routine and preliminary examination. To provide efficient quality control of Carvedilol formulations, the choice of a suitable analytical method ultimately depends on the intended use, necessary sensitivity, and available resources.

REFERENCES

  1. Indian Pharmacopoeia Commission. Indian Pharmacopoeia. Ghaziabad: IPC; 2018.
  2. United States Pharmacopeia Convention. USP 43–NF 38. Rockville: USP; 2020.
  3. International Council for Harmonisation. ICH Q2(R1): Validation of Analytical Procedures. Geneva: ICH; 2005.
  4. Snyder LR, Kirkland JJ, Dolan JW. Introduction to Modern Liquid Chromatography. 3rd ed. New York: Wiley; 2010.
  5. Beckett AH, Stenlake JB. Practical Pharmaceutical Chemistry. 4th ed. New Delhi: CBS Publishers; 2002.
  6. Chatwal GR, Anand SK. Instrumental Methods of Chemical Analysis. Mumbai: Himalaya Publishing House; 2007.
  7. Skoog DA, Holler FJ, Crouch SR. Principles of Instrumental Analysis. 6th ed. USA: Cengage Learning; 2007.
  8. Willard HH, Merritt LL, Dean JA. Instrumental Methods of Analysis. 7th ed. New Delhi: CBS; 1986.
  9. Sharma BK. Instrumental Methods of Chemical Analysis. 24th ed. Meerut: Goel Publishing; 2005.
  10. Vogel AI. Textbook of Quantitative Chemical Analysis. 6th ed. England: Pearson; 2000.
  11. Bakshi M, Singh S. Development of validated stability-indicating assay methods. J Pharm Biomed Anal. 2002;28(6):1011–40.
  12. Blessy M, Patel RD, Prajapati PN, Agrawal YK. Development of forced degradation studies. J Pharm Anal. 2014;4(3):159–65.
  13. Swartz ME, Krull IS. Analytical Method Development and Validation. New York: Marcel Dekker; 2012.
  14. Kazakevich Y, Lobrutto R. HPLC for Pharmaceutical Scientists. New Jersey: Wiley; 2007.
  15. Meyer VR. Practical High-Performance Liquid Chromatography. 5th ed. UK: Wiley; 2010.
  16. Patel DK, Patel NJ. Development and validation of RP-HPLC method for Carvedilol. Int J Pharm Sci Res. 2013;4(5):1901–5.
  17. Sharma P, Kaur G. UV spectrophotometric method for estimation of Carvedilol. Int J Pharm Sci Rev Res. 2012;14(2):45–8.
  18. Gupta KR, Askarkar SS. RP-HPLC method development for Carvedilol. Int J Pharm Sci. 2009;1(2):123–7.
  19. Patil SD, et al. Stability-indicating HPLC method for Carvedilol. J Chem Pharm Res. 2011;3(4):678–84.
  20. Reddy KR, et al. Analytical method development of Carvedilol. Asian J Pharm Clin Res. 2010;3(1):34–7.
  21. ICH Q1A(R2): Stability Testing Guidelines. Geneva: ICH; 2003.
  22. FDA. Guidance for Industry: Analytical Procedures and Methods Validation. USA: FDA; 2015.
  23. EMA. Guideline on Validation of Analytical Methods. London: EMA; 2011.
  24. Snyder LR. Practical HPLC Method Development. 2nd ed. New York: Wiley; 1997.
  25. Christian GD. Analytical Chemistry. 6th ed. New York: Wiley; 2004.
  26. Singh R, et al. UV method for Carvedilol tablets. Int J Pharm Tech Res. 2011;3(2):845–9.
  27. Patel RB, et al. RP-HPLC estimation of Carvedilol. Int J Pharm Sci Rev. 2012;15(1):67–70.
  28. Shah DA, et al. Stability indicating method for Carvedilol. J Pharm Sci. 2013;102(3):1112–8.
  29. Kulkarni MV, et al. HPLC analysis of beta-blockers. Indian J Pharm Sci. 2010;72(5):543–7.
  30. Jain PS, et al. Analytical method validation of Carvedilol. J Pharm Res. 2012;5(3):1542–6.
  31. Sethi PD. Quantitative Analysis of Drugs in Pharmaceutical Formulations. 3rd ed. New Delhi: CBS; 2008.
  32. Ermer J, Miller JHM. Method Validation in Pharmaceutical Analysis. Germany: Wiley-VCH; 2005.
  33. Dong MW. Modern HPLC for Practicing Scientists. New Jersey: Wiley; 2006.
  34. Harris DC. Quantitative Chemical Analysis. 9th ed. New York: Freeman; 2015.
  35. Kellner R, et al. Analytical Chemistry. Germany: Wiley-VCH; 2004.
  36. Rao RN, Nagaraju V. Stability indicating HPLC method. J Pharm Biomed Anal. 2003;33(3):335–77.
  37. Blessy M, et al. Forced degradation study of drugs. J Pharm Anal. 2014;4(3):159–65.
  38. Patel JK, et al. UV method validation for drugs. Int J Pharm Sci. 2011;3(4):123–7.
  39. Sharma MC, et al. RP-HPLC method for drug analysis. Asian J Pharm. 2012;6(2):78–82.
  40. Gupta A, et al. Method development using HPLC. J Chem Pharm Res. 2013;5(5):200–6.
  41. British Pharmacopoeia Commission. British Pharmacopoeia. London: BP; 2019.
  42. AOAC International. Official Methods of Analysis. 20th ed. USA: AOAC; 2016.
  43. Nash RA, Wachter AH. Pharmaceutical Process Validation. 3rd ed. New York: CRC Press; 2003.
  44. Carstensen JT. Drug Stability: Principles and Practices. 3rd ed. New York: CRC Press; 2000.
  45. Ahuja S, Dong MW. Handbook of Pharmaceutical Analysis by HPLC. Elsevier; 2005.
  46. Singh S, Bakshi M. Guidance on forced degradation studies. Pharm Technol. 2000;24(2):1–14.
  47. Ravisankar P, et al. HPLC method development review. J Chem Pharm Sci. 2014;7(2):80–5.
  48. Kaushal C, et al. Analytical validation parameters. Int J Pharm Sci Rev Res. 2011;5(2):78–82.
  49. Kumar V, et al. RP-HPLC analytical method review. Int J Res Pharm Chem. 2012;2(3):566–70.
  50. Patel PM, et al. UV and HPLC methods for beta blockers. Int J Pharm Sci Rev Res. 2013;21(1):112–6.

Reference

  1. Indian Pharmacopoeia Commission. Indian Pharmacopoeia. Ghaziabad: IPC; 2018.
  2. United States Pharmacopeia Convention. USP 43–NF 38. Rockville: USP; 2020.
  3. International Council for Harmonisation. ICH Q2(R1): Validation of Analytical Procedures. Geneva: ICH; 2005.
  4. Snyder LR, Kirkland JJ, Dolan JW. Introduction to Modern Liquid Chromatography. 3rd ed. New York: Wiley; 2010.
  5. Beckett AH, Stenlake JB. Practical Pharmaceutical Chemistry. 4th ed. New Delhi: CBS Publishers; 2002.
  6. Chatwal GR, Anand SK. Instrumental Methods of Chemical Analysis. Mumbai: Himalaya Publishing House; 2007.
  7. Skoog DA, Holler FJ, Crouch SR. Principles of Instrumental Analysis. 6th ed. USA: Cengage Learning; 2007.
  8. Willard HH, Merritt LL, Dean JA. Instrumental Methods of Analysis. 7th ed. New Delhi: CBS; 1986.
  9. Sharma BK. Instrumental Methods of Chemical Analysis. 24th ed. Meerut: Goel Publishing; 2005.

Photo
Dipa kakde
Corresponding author

Dr. Vedprakash Patil pharmacy college, Chhatrapati Sambhajinagar, Maharashtra 431105.

Photo
Prof. Sameer Ahmed
Co-author

Dr. Vedprakash Patil pharmacy college, Chhatrapati Sambhajinagar, Maharashtra 431105.

Prof. Sameer Ahmed, Dipa Kakde, Analytical Method Development and Validation of Carvedilol Using Uv and RP-HPLC Techniques, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 5, 1390-1398, https://doi.org/10.5281/zenodo.20067867

More related articles
A Comprehensive Review on the Antibacterial Activi...
A. Sneha, K. B Ilango, K. Abitha, B. Harini, P. V. Harivarshan, B...
ORAL MANIFESTATIONS OF VARIOUS SYNDROMES :A REVIEW...
Radhika Gupta, Trushna Rahangdale, ...
Artificial Intelligence in Community Pharmacy: Bri...
Aarti Aher, Jadhav Sakshi , Dhanashri Mali, Shubham Pachorkar , ...
Standard Operating Procedure (SOP): A Review...
Harshit Sharma, Vipin Kukkar, ...
A Study On Antimicrobial Activity Of Lantana Camara...
Anshika Rathore , B. N. Birla , Vivek Yadav , Aman Karma , Sonali Patidar , ...
Formulation and Evaluation of Novel Polyherbal Toothpaste ...
Anshul Burande , Abhay Zadokar , Abhishek Deshmukh , Adesh Nikam, Akash Avachar, Dr. Aditya Gattani...
Related Articles
Article Intelligence and Digital Transformation of Pharmacy...
Prajakta Pawar, Priyanka Mudgan, Dhanshree More, Siddhi Kothare, ...
Nurturing Hormones: The Role Of Fortified Noodles In Adolescent Health...
Sayali kishor patil, Mugdha A. Joshi, Digvijay J . Patil, Sagar A. Dudhade, ...
Personalized Medicine Approaches in the Treatment Of Mental Health Disorder...
Mr. Swapnil D. Aade, Prof. Zameer M. Shah, Dr. Shivshankar D. Mhaske, Prof. Tejas J. Sharma, ...
A Comprehensive Review on the Antibacterial Activity of Setaria italica (L.) Hus...
A. Sneha, K. B Ilango, K. Abitha, B. Harini, P. V. Harivarshan, B. Ranjithkumar, A. Shanmugapriyan, ...
More related articles
A Comprehensive Review on the Antibacterial Activity of Setaria italica (L.) Hus...
A. Sneha, K. B Ilango, K. Abitha, B. Harini, P. V. Harivarshan, B. Ranjithkumar, A. Shanmugapriyan, ...
ORAL MANIFESTATIONS OF VARIOUS SYNDROMES :A REVIEW...
Radhika Gupta, Trushna Rahangdale, ...
Artificial Intelligence in Community Pharmacy: Bridging Human Touch with Digital...
Aarti Aher, Jadhav Sakshi , Dhanashri Mali, Shubham Pachorkar , Dr. M.R.N Shaikh, ...
A Comprehensive Review on the Antibacterial Activity of Setaria italica (L.) Hus...
A. Sneha, K. B Ilango, K. Abitha, B. Harini, P. V. Harivarshan, B. Ranjithkumar, A. Shanmugapriyan, ...
ORAL MANIFESTATIONS OF VARIOUS SYNDROMES :A REVIEW...
Radhika Gupta, Trushna Rahangdale, ...
Artificial Intelligence in Community Pharmacy: Bridging Human Touch with Digital...
Aarti Aher, Jadhav Sakshi , Dhanashri Mali, Shubham Pachorkar , Dr. M.R.N Shaikh, ...